These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 11660533

  • 41. Annual review: observed deficiencies and suggested corrections.
    Adams MS, Conrad DA.
    IRB; 1996; 18(6):1-4. PubMed ID: 11654743
    [No Abstract] [Full Text] [Related]

  • 42. Continuing review of research involving human subjects: approach to the problem and remaining areas of concern.
    Gordon B, Prentice E.
    IRB; 1997; 19(2):8-11. PubMed ID: 11655323
    [No Abstract] [Full Text] [Related]

  • 43. Informed consent in the clinical research setting: experimentation on human subjects.
    Owens JF.
    Med Trial Tech Q; 1987; 33(3):335-50. PubMed ID: 11653829
    [No Abstract] [Full Text] [Related]

  • 44. The impact of institutional review boards on clinical research.
    Levine RJ.
    Perspect Biol Med; 1987; 23(2):. PubMed ID: 11663073
    [No Abstract] [Full Text] [Related]

  • 45. Reviewing subject recruitment: new rules from Rockville.
    McMahon FG.
    IRB; 1988; 10(3):6-7. PubMed ID: 11651911
    [No Abstract] [Full Text] [Related]

  • 46. Regulation of clinical research: who's protecting who from what?
    Petricciani JC.
    Food Drug Cosmet Law J; 1979 Apr; 34(4):205-7. PubMed ID: 11661718
    [No Abstract] [Full Text] [Related]

  • 47. A military exception to "informed consent": Doe v. Sullivan.
    Moran PJ.
    St Johns Law Rev; 1993 Apr; 66(3):847-63. PubMed ID: 11652729
    [No Abstract] [Full Text] [Related]

  • 48. Bill of rights for research subjects.
    Prentice ED, Reitemeier PJ, Antonson DL, Kelso TK, Jameton A.
    IRB; 1993 Apr; 15(2):7-9. PubMed ID: 11651568
    [No Abstract] [Full Text] [Related]

  • 49. Institutional review boards, genetic research, and privacy.
    Maloney DM.
    Hum Res Rep; 1996 Sep; 11(9):6. PubMed ID: 11660229
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
    Dunbar MM.
    Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
    [No Abstract] [Full Text] [Related]

  • 53. Ethical aspects of pharmaceutically-based clinical investigation: report on a national workshop.
    Miller J, Kinsella D, Klein A, Rusted I.
    NCBHR Commun; 1990 Sep; 1(1):7-10. PubMed ID: 11660185
    [No Abstract] [Full Text] [Related]

  • 54. National commission proposes numerous new regulations of institutional review boards.
    Maloney DM.
    Hum Res Rep; 1998 Oct; 13(10):1-2. PubMed ID: 11657739
    [No Abstract] [Full Text] [Related]

  • 55. All is not well in research on human subjects.
    Goldman J.
    N Y Times Web; 1986 Mar 06; ():A26. PubMed ID: 11647822
    [No Abstract] [Full Text] [Related]

  • 56. Protection of human subjects.
    United States.
    Code Fed Regul Shipping; 1982 Oct 01; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
    [No Abstract] [Full Text] [Related]

  • 57. Human experimentation: the regulation controversy.
    Society; 1975 Oct 01; 13(1):4-12. PubMed ID: 11662982
    [No Abstract] [Full Text] [Related]

  • 58. The Food and Drug Administration's role in the protection of human subjects.
    Nightingale SL.
    IRB; 1983 Oct 01; 5(1):6-9. PubMed ID: 11649511
    [No Abstract] [Full Text] [Related]

  • 59. Limited guardianship: additional protection for mentally disabled research subjects used in biomedical and behavioral research.
    Schaefer GF.
    Forum; 1981 Oct 01; 16(4):796-824. PubMed ID: 11651838
    [No Abstract] [Full Text] [Related]

  • 60. An overview of FDA, IRBs and regulations.
    Petricciani JC.
    IRB; 1981 Dec 01; 3(10):1-3, 11. PubMed ID: 11649413
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.